Cargando…

An artificial immune system with bootstrap sampling for the diagnosis of recurrent endometrial cancers

Endometrial cancer is one of the most common gynecological malignancies in developed countries. The prevention of the recurrence of endometrial cancer has always been a clinical challenge. Endometrial cancer is asymptomatic in the early stage, and there remains a lack of time-series correlation patt...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chih-Yen, Lu, Yen-Chiao (Angel), Ting, Wen-Chien, Shen, Tsu-Wang (David), Peng, Wen-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863001/
https://www.ncbi.nlm.nih.gov/pubmed/33585700
http://dx.doi.org/10.1515/med-2021-0226
_version_ 1783647414944530432
author Chang, Chih-Yen
Lu, Yen-Chiao (Angel)
Ting, Wen-Chien
Shen, Tsu-Wang (David)
Peng, Wen-Chen
author_facet Chang, Chih-Yen
Lu, Yen-Chiao (Angel)
Ting, Wen-Chien
Shen, Tsu-Wang (David)
Peng, Wen-Chen
author_sort Chang, Chih-Yen
collection PubMed
description Endometrial cancer is one of the most common gynecological malignancies in developed countries. The prevention of the recurrence of endometrial cancer has always been a clinical challenge. Endometrial cancer is asymptomatic in the early stage, and there remains a lack of time-series correlation patterns of clinical pathway transfer, recurrence, and treatment. In this study, the artificial immune system (AIS) combined with bootstrap sampling was compared with other machine learning techniques, which included both supervised and unsupervised learning categories. The back propagation neural network, support vector machine (SVM) with a radial basis function kernel, fuzzy c-means, and ant k-means were compared with the proposed method to verify the sensitivity and specificity of the datasets, and the important factors of recurrent endometrial cancer were predicted. In the unsupervised learning algorithms, the AIS algorithm had the highest accuracy (83.35%), sensitivity (77.35%), and specificity (92.31%); in supervised learning algorithms, the SVM algorithm had the highest accuracy (97.51%), sensitivity (95.02%), and specificity (99.29%). The results of our study showed that histology and chemotherapy are important factors affecting the prediction of recurrence. Finally, behavior code and radiotherapy for recurrent endometrial cancer are important factors for future adjuvant treatment.
format Online
Article
Text
id pubmed-7863001
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-78630012021-02-12 An artificial immune system with bootstrap sampling for the diagnosis of recurrent endometrial cancers Chang, Chih-Yen Lu, Yen-Chiao (Angel) Ting, Wen-Chien Shen, Tsu-Wang (David) Peng, Wen-Chen Open Med (Wars) Research Article Endometrial cancer is one of the most common gynecological malignancies in developed countries. The prevention of the recurrence of endometrial cancer has always been a clinical challenge. Endometrial cancer is asymptomatic in the early stage, and there remains a lack of time-series correlation patterns of clinical pathway transfer, recurrence, and treatment. In this study, the artificial immune system (AIS) combined with bootstrap sampling was compared with other machine learning techniques, which included both supervised and unsupervised learning categories. The back propagation neural network, support vector machine (SVM) with a radial basis function kernel, fuzzy c-means, and ant k-means were compared with the proposed method to verify the sensitivity and specificity of the datasets, and the important factors of recurrent endometrial cancer were predicted. In the unsupervised learning algorithms, the AIS algorithm had the highest accuracy (83.35%), sensitivity (77.35%), and specificity (92.31%); in supervised learning algorithms, the SVM algorithm had the highest accuracy (97.51%), sensitivity (95.02%), and specificity (99.29%). The results of our study showed that histology and chemotherapy are important factors affecting the prediction of recurrence. Finally, behavior code and radiotherapy for recurrent endometrial cancer are important factors for future adjuvant treatment. De Gruyter 2021-01-29 /pmc/articles/PMC7863001/ /pubmed/33585700 http://dx.doi.org/10.1515/med-2021-0226 Text en © 2021 Chih-Yen Chang et al., published by De Gruyter http://creativecommons.org/licenses/by/4.0 This work is licensed under the Creative Commons Attribution 4.0 International License.
spellingShingle Research Article
Chang, Chih-Yen
Lu, Yen-Chiao (Angel)
Ting, Wen-Chien
Shen, Tsu-Wang (David)
Peng, Wen-Chen
An artificial immune system with bootstrap sampling for the diagnosis of recurrent endometrial cancers
title An artificial immune system with bootstrap sampling for the diagnosis of recurrent endometrial cancers
title_full An artificial immune system with bootstrap sampling for the diagnosis of recurrent endometrial cancers
title_fullStr An artificial immune system with bootstrap sampling for the diagnosis of recurrent endometrial cancers
title_full_unstemmed An artificial immune system with bootstrap sampling for the diagnosis of recurrent endometrial cancers
title_short An artificial immune system with bootstrap sampling for the diagnosis of recurrent endometrial cancers
title_sort artificial immune system with bootstrap sampling for the diagnosis of recurrent endometrial cancers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863001/
https://www.ncbi.nlm.nih.gov/pubmed/33585700
http://dx.doi.org/10.1515/med-2021-0226
work_keys_str_mv AT changchihyen anartificialimmunesystemwithbootstrapsamplingforthediagnosisofrecurrentendometrialcancers
AT luyenchiaoangel anartificialimmunesystemwithbootstrapsamplingforthediagnosisofrecurrentendometrialcancers
AT tingwenchien anartificialimmunesystemwithbootstrapsamplingforthediagnosisofrecurrentendometrialcancers
AT shentsuwangdavid anartificialimmunesystemwithbootstrapsamplingforthediagnosisofrecurrentendometrialcancers
AT pengwenchen anartificialimmunesystemwithbootstrapsamplingforthediagnosisofrecurrentendometrialcancers
AT changchihyen artificialimmunesystemwithbootstrapsamplingforthediagnosisofrecurrentendometrialcancers
AT luyenchiaoangel artificialimmunesystemwithbootstrapsamplingforthediagnosisofrecurrentendometrialcancers
AT tingwenchien artificialimmunesystemwithbootstrapsamplingforthediagnosisofrecurrentendometrialcancers
AT shentsuwangdavid artificialimmunesystemwithbootstrapsamplingforthediagnosisofrecurrentendometrialcancers
AT pengwenchen artificialimmunesystemwithbootstrapsamplingforthediagnosisofrecurrentendometrialcancers